Surveillance of antibiotic resistance in ICUs in southeastern Sweden

Acta Anaesthesiologica Scandinavica

Volumn 43, Issue 8, 1999, Pages 815-820

  Erlandsson, C M ^a   Hanberger, H ^a   Eliasson, I ^b   Hoffmann, M ^a   Isaksson, B ^a   Lindgren, S ^e   Nilsson, L E ^a   Soren L ^c   Walther, S M ^d  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

^c Department of Clinical Microbiology   (Sweden)

^d Departments of Surgery and Urology   (Sweden)

^e NONE

Author keywords

Antibiotic consumption; Antibiotic resistance; ICU infections; Intensive care units

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; FUSIDIC ACID; IMIPENEM; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; RIFAMPICIN; TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SURVEILLANCE PROGRAM; DRUG USE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; INTENSIVE CARE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SWEDEN;

EID: 0032839174     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.1999.430806.x     Document Type: Article

References (24)

1. 1. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 1995: 274: 639-644.
2. 2. Rice LB, Willey SH, Papanicolaou GA et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990: 34: 2193-2199.
3. 3. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993: 119: 353-358.
4. 4. Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R. Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994: 38: 681-687.
5. 5. Burwen DR, Banerjee SN, Gaynes RP and the National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 1994: 170: 1622-1625.
6. 6. Richard P, Delangle M-H, Merrien D et al. Fluoroquinolone use and fluoroquinolone resistance: Is there an association? Clin Infect Dis 1994: 19: 54-59.
7. 7. Jacobson KL, Cohen SH, Inciardi JF et al. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin Infect Dis 1995: 21: 1107-1113.
8. 8. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995: 8: 557-584.
9. 9. Davin-Regli A, Monnet D, Saux P et al. Molecular epidemiology of Enterobacter aerogenes acquistion: one year prospective study in two intensive care units. J Clin Microbiol 1996: 34: 1474-1480.
10. 10. Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 1996: 23: 779-784.
11. 11. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp from intensive care units in Europe. J Antimicrob Chemother 1996: 38: 409-424.
12. 12. De Gheldre Y, Maes N, Rost F et al. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 1997: 35: 152-160.
13. 13. Kollef MH. Antibiotic use and antibiotic resistance in the intensive care unit: Are we curing or creating disease? Heart Lung 1994: 23: 363-367.
14. 14. Cassell GH, Archer GL, Beam TR et al. Reports of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 1995: 39 (suppl): S1-S23.
15. 15. Riley TV, Webb SAR, Cadwallader H, Briggs BD, Christiansen L, Bowman RA. Outbreak of gentamicin resistant Acinetobacter baumanii in an intensive care unit - clinical, epidemiologic and microbiological features. J Pathol 1996: 28: 359-363.
16. 16. Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Med 1994: 20 (suppl): S1-S4.
17. 17. Widmer AF. Infection control and prevention strategies in the ICU. Intensive Care Med 1994: 20 (suppl): S7-S11.
18. 18. Emori TG, Culver DH, Horan TC et al. National Nosocomial Infections Surveillance (NNIS) system: description of surveillance methodology. Am J Infect Control 1991: 19: 19-35.
19. 19. Hanberger H, Nilsson LE. High frequency of antibiotic resistance among gram-negative isolates in intensive care units at ten swedish hospitals. Clin Microbiol Chemother 1997: 3: 208-215.
20. 20. Hanberger H, Hoffmann M, Lindgren S, Nilsson LE. High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis 1997: 29: 607-614.
21. 21. Hanberger H, Garcia-Rodriguez JA, Goossens H et al. Antibiotic susceptibility among aerobic gramnegative bacilli in intensive care units in 5 European countries. JAMA 1999: 281: 67-71.
22. 22. Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Methodology for susceptibility testing. Scand J Infect Dis 1997; 105 (suppl): S13-S23.
23. 23. Keita-Perse O, Gaynes RP. Severity of illness scoring systems to adjust nosocomial infection rates: A review and commentary. Am J Infect Control 1996: 24: 429-434.
24. 24. Walker RD, Thornsberry C. Decrease in antibiotic susceptibility or increase in resistance? J Antimicrob Chemother 1998: 41: 1-4.